Literature DB >> 32115648

Resection of the irradiated esophagus: the impact of lymph node yield on survival.

V R Esposito1, B A Yerokun2, M S Mulvihill2, M L Cox2, B Y Andrew1, C J Yang2, A Y Choi1, C Moore2, T A D'Amico2, B C Tong2, M G Hartwig2.   

Abstract

There is debate surrounding the appropriate threshold for lymph node harvest during esophagectomy in patients with esophageal cancer, specifically for those receiving preoperative radiation. The purpose of this study was to determine the impact of lymph node yield on survival in patients receiving preoperative chemoradiation for esophageal cancer. The National Cancer Database (NCDB) was utilized to identify patients with esophageal cancer that received preoperative radiation. The cohort was divided into patients undergoing minimal (<9) or extensive (≥9) lymph node yield. Demographic, operative, and postoperative outcomes were compared between the groups. Kaplan-Meier analysis with the log rank test was used to compare survival between the yield groups. Cox proportional hazards model was used to determine the association between lymph node yield and survival. In total, 886 cases were included: 349 (39%) belonging to the minimal node group and 537 (61%) to the extensive group. Unadjusted 5-year survival was similar between the minimal and extensive groups, respectively (37.3% vs. 38.8%; P > 0.05). After adjustment using Cox regression, extensive lymph node yield was associated with survival (hazard ratio 0.80, confidence interval 0.66-0.98, P = 0.03). This study suggests that extensive lymph node yield is advantageous for patients with esophageal cancer undergoing esophagectomy following induction therapy. This most likely reflects improved diagnosis and staging with extensive yield.
© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  esophageal cancer; esophagectomy; induction radiation; lymph node; preoperative radiation

Mesh:

Year:  2020        PMID: 32115648      PMCID: PMC7548436          DOI: 10.1093/dote/doaa007

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  10 in total

1.  Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy.

Authors:  C S Wolff; S F Castillo; D R Larson; M M O'Byrne; M Fredericksen; C Deschamps; M S Allen; T G Zais; Y Romero
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

2.  Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.

Authors:  Ravi Shridhar; Sarah E Hoffe; Khaldoun Almhanna; Jill M Weber; Michael D Chuong; Richard C Karl; Kenneth Meredith
Journal:  Ann Surg Oncol       Date:  2013-04-28       Impact factor: 5.344

3.  Extent of lymph node removal during esophageal cancer surgery and survival.

Authors:  Maartje van der Schaaf; Asif Johar; Bas Wijnhoven; Pernilla Lagergren; Jesper Lagergren
Journal:  J Natl Cancer Inst       Date:  2015-03-05       Impact factor: 13.506

4.  The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer.

Authors:  Jennifer M Hanna; Loretta Erhunmwunsee; Mark Berry; Thomas D'Amico; Mark Onaitis
Journal:  Ann Thorac Surg       Date:  2014-11-20       Impact factor: 4.330

5.  Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Authors:  A Koen Talsma; Joel Shapiro; Caspar W N Looman; Pieter van Hagen; Ewout W Steyerberg; Ate van der Gaast; Mark I van Berge Henegouwen; Bas P L Wijnhoven; J Jan B van Lanschot; Maarten C C M Hulshof; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W ten Kate; Geert-Jan Creemers; Cornelis J A Punt; John T M Plukker; Henk M W Verheul; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

6.  Variation in lymph node examination after esophagectomy for cancer in the United States.

Authors:  Ryan P Merkow; Karl Y Bilimoria; Warren B Chow; Justin S Merkow; Michael J Weyant; Clifford Y Ko; David J Bentrem
Journal:  Arch Surg       Date:  2012-06

7.  Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival.

Authors:  Pamela Samson; Traves Crabtree; Stephen Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2016-09-21       Impact factor: 4.330

8.  Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.

Authors:  Jesper Lagergren; Fredrik Mattsson; Janine Zylstra; Fuju Chang; James Gossage; Robert Mason; Pernilla Lagergren; Andrew Davies
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

9.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344

10.  Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer.

Authors:  San-Gang Wu; Zhao-Qiang Zhang; Wen-Ming Liu; Zhen-Yu He; Feng-Yan Li; Huan-Xin Lin; Jia-Yuan Sun; Hui Lin; Qun Li
Journal:  Oncotarget       Date:  2016-04-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.